Annual Accounts Payable
$770.00 K
-$145.00 K-15.85%
31 December 2023
Summary:
Theriva Biologics annual accounts payable is currently $770.00 thousand, with the most recent change of -$145.00 thousand (-15.85%) on 31 December 2023. During the last 3 years, it has fallen by -$116.00 thousand (-13.09%). TOVX annual accounts payable is now -82.55% below its all-time high of $4.41 million, reached on 01 December 2015.TOVX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$756.00 K
-$179.00 K-19.14%
01 September 2024
Summary:
Theriva Biologics quarterly accounts payable is currently $756.00 thousand, with the most recent change of -$179.00 thousand (-19.14%) on 01 September 2024. Over the past year, it has dropped by -$77.00 thousand (-9.24%). TOVX quarterly accounts payable is now -91.30% below its all-time high of $8.69 million, reached on 01 June 2015.TOVX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.8% | -9.2% |
| 3 y3 years | -13.1% | +44.3% |
| 5 y5 years | -66.7% | -67.3% |
TOVX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -15.8% | +47.0% | -44.2% | +57.5% |
| 5 y | 5 years | -66.7% | +47.0% | -67.3% | +57.5% |
| alltime | all time | -82.5% | +670.0% | -91.3% | +656.0% |
Theriva Biologics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $756.00 K(-19.1%) |
| June 2024 | - | $935.00 K(+63.7%) |
| Mar 2024 | - | $571.00 K(-25.8%) |
| Dec 2023 | $770.00 K(-15.8%) | $770.00 K(-7.6%) |
| Sept 2023 | - | $833.00 K(+12.4%) |
| June 2023 | - | $741.00 K(+54.4%) |
| Mar 2023 | - | $480.00 K(-47.5%) |
| Dec 2022 | $915.00 K(+74.6%) | $915.00 K(+18.8%) |
| Sept 2022 | - | $770.00 K(-23.2%) |
| June 2022 | - | $1.00 M(-25.9%) |
| Mar 2022 | - | $1.35 M(+158.4%) |
| Dec 2021 | $524.00 K(-40.9%) | - |
| Dec 2021 | - | $524.00 K(-58.2%) |
| Sept 2021 | - | $1.25 M(+121.0%) |
| June 2021 | - | $568.00 K(-8.5%) |
| Mar 2021 | - | $621.00 K(-29.9%) |
| Dec 2020 | $886.00 K(-61.7%) | $886.00 K(-10.7%) |
| Sept 2020 | - | $992.00 K(-3.2%) |
| June 2020 | - | $1.02 M(-17.8%) |
| Mar 2020 | - | $1.25 M(-46.1%) |
| Dec 2019 | $2.31 M(+123.9%) | $2.31 M(-5.6%) |
| Sept 2019 | - | $2.45 M(+61.0%) |
| June 2019 | - | $1.52 M(+98.8%) |
| Mar 2019 | - | $766.00 K(-25.9%) |
| Dec 2018 | $1.03 M(-48.8%) | $1.03 M(+17.6%) |
| Sept 2018 | - | $879.00 K(-27.8%) |
| June 2018 | - | $1.22 M(-18.5%) |
| Mar 2018 | - | $1.49 M(-26.1%) |
| Dec 2017 | $2.02 M(+1.4%) | $2.02 M(+84.1%) |
| Sept 2017 | - | $1.10 M(-36.3%) |
| June 2017 | - | $1.72 M(-54.6%) |
| Mar 2017 | - | $3.80 M(+90.5%) |
| Dec 2016 | $1.99 M(-54.8%) | $1.99 M(-53.0%) |
| Sept 2016 | - | $4.24 M(-6.9%) |
| June 2016 | - | $4.56 M(-0.9%) |
| Mar 2016 | - | $4.60 M(+4.2%) |
| Dec 2015 | $4.41 M(+343.1%) | $4.41 M(-26.8%) |
| Sept 2015 | - | $6.03 M(-30.6%) |
| June 2015 | - | $8.69 M(+457.2%) |
| Mar 2015 | - | $1.56 M(+56.5%) |
| Dec 2014 | $996.00 K(+601.4%) | $996.00 K(+14.1%) |
| Sept 2014 | - | $873.00 K(-19.1%) |
| June 2014 | - | $1.08 M(+39.6%) |
| Mar 2014 | - | $773.00 K(+444.4%) |
| Dec 2013 | $142.00 K(-64.1%) | $142.00 K(-75.7%) |
| Sept 2013 | - | $584.00 K(+174.2%) |
| June 2013 | - | $213.00 K(+8.7%) |
| Mar 2013 | - | $196.00 K(-50.4%) |
| Dec 2012 | $395.00 K(+1.8%) | $395.00 K(+1.3%) |
| Sept 2012 | - | $390.00 K(+40.3%) |
| June 2012 | - | $278.00 K(-12.0%) |
| Mar 2012 | - | $316.00 K(-18.6%) |
| Dec 2011 | $388.00 K | $388.00 K(+101.0%) |
| Sept 2011 | - | $193.00 K(-32.7%) |
| June 2011 | - | $286.80 K(-19.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2011 | - | $355.10 K(+33.5%) |
| Dec 2010 | $266.00 K(-33.6%) | $266.00 K(-13.4%) |
| Sept 2010 | - | $307.10 K(-10.5%) |
| June 2010 | - | $343.30 K(+2.4%) |
| Mar 2010 | - | $335.30 K(-16.3%) |
| Dec 2009 | $400.50 K(-30.3%) | $400.50 K(+56.5%) |
| Sept 2009 | - | $255.90 K(-31.0%) |
| June 2009 | - | $370.80 K(-29.0%) |
| Mar 2009 | - | $522.60 K(-9.1%) |
| Dec 2008 | $574.90 K(-21.0%) | $574.90 K(+14.8%) |
| Sept 2008 | - | $500.60 K(-21.4%) |
| June 2008 | - | $637.00 K(-36.7%) |
| Mar 2008 | - | $1.01 M(+38.3%) |
| Dec 2007 | $728.10 K(+34.8%) | $728.10 K(-0.2%) |
| Sept 2007 | - | $729.60 K(+2.7%) |
| June 2007 | - | $710.70 K(+76.8%) |
| Mar 2007 | - | $401.90 K(-25.6%) |
| Dec 2006 | $540.10 K(+151.9%) | $540.10 K(-78.9%) |
| Dec 2005 | $214.40 K(-91.7%) | - |
| Mar 2003 | - | $2.56 M(-1.4%) |
| Dec 2002 | $2.60 M(+203.5%) | $2.60 M(+10.3%) |
| Sept 2002 | - | $2.35 M(+4.0%) |
| June 2002 | - | $2.26 M(+7.6%) |
| Mar 2002 | - | $2.10 M(+145.6%) |
| Dec 2001 | $856.20 K(-30.7%) | $856.20 K(-10.4%) |
| Sept 2001 | - | $955.40 K(-40.1%) |
| June 2001 | - | $1.59 M(+89.8%) |
| Mar 2001 | - | $840.50 K(-31.9%) |
| Dec 2000 | $1.23 M(+59.7%) | $1.23 M(+159.3%) |
| Sept 2000 | - | $476.20 K(-6.4%) |
| June 2000 | - | $508.70 K(-2.0%) |
| Mar 2000 | - | $519.10 K(-32.9%) |
| Dec 1999 | $773.20 K(+28.9%) | $773.20 K(+28.9%) |
| Sept 1999 | - | $600.00 K(+20.0%) |
| June 1999 | - | $500.00 K(-16.7%) |
| Mar 1999 | - | $600.00 K(0.0%) |
| Dec 1998 | $600.00 K(-33.3%) | $600.00 K(+20.0%) |
| Sept 1998 | - | $500.00 K(-28.6%) |
| June 1998 | - | $700.00 K(-73.1%) |
| Mar 1998 | - | $2.60 M(+188.9%) |
| Dec 1997 | $900.00 K(+125.0%) | $900.00 K(+12.5%) |
| Sept 1997 | - | $800.00 K(+60.0%) |
| June 1997 | - | $500.00 K(+66.7%) |
| Mar 1997 | - | $300.00 K(-25.0%) |
| Dec 1996 | $400.00 K(+300.0%) | $400.00 K(0.0%) |
| Sept 1996 | - | $400.00 K(+100.0%) |
| June 1996 | - | $200.00 K(0.0%) |
| Mar 1996 | - | $200.00 K(+100.0%) |
| Dec 1995 | $100.00 K(-83.3%) | $100.00 K(-50.0%) |
| Sept 1995 | - | $200.00 K(-66.7%) |
| Dec 1994 | $600.00 K(+200.0%) | $600.00 K(+200.0%) |
| Mar 1994 | - | $200.00 K(0.0%) |
| Dec 1993 | $200.00 K | $200.00 K(+100.0%) |
| June 1993 | - | $100.00 K(-50.0%) |
| Mar 1993 | - | $200.00 K |
FAQ
- What is Theriva Biologics annual accounts payable?
- What is the all time high annual accounts payable for Theriva Biologics?
- What is Theriva Biologics annual accounts payable year-on-year change?
- What is Theriva Biologics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Theriva Biologics?
- What is Theriva Biologics quarterly accounts payable year-on-year change?
What is Theriva Biologics annual accounts payable?
The current annual accounts payable of TOVX is $770.00 K
What is the all time high annual accounts payable for Theriva Biologics?
Theriva Biologics all-time high annual accounts payable is $4.41 M
What is Theriva Biologics annual accounts payable year-on-year change?
Over the past year, TOVX annual accounts payable has changed by -$145.00 K (-15.85%)
What is Theriva Biologics quarterly accounts payable?
The current quarterly accounts payable of TOVX is $756.00 K
What is the all time high quarterly accounts payable for Theriva Biologics?
Theriva Biologics all-time high quarterly accounts payable is $8.69 M
What is Theriva Biologics quarterly accounts payable year-on-year change?
Over the past year, TOVX quarterly accounts payable has changed by -$77.00 K (-9.24%)